ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloksetin - neuralgia; diabetic neuropathies; depressive disorder, major - psychoanaleptics, - duloxetine lilly er indisert hos voksne:behandling av depressive disordertreatment av diabetiker perifer nevropatisk paintreatment av generell angst disorderduloxetine lilly er indisert hos voksne.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

eli lilly nederland b.v. - duloksethydroklorid - urininkontinens, stress - psychoanaleptics, - yentreve er indisert for kvinner til behandling av moderat til alvorlig stressurininkontinens (sui).

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

vanda pharmaceuticals netherlands b.v. - tasimelteon - søvnforstyrrelser, sirkadisk rytme - psykoleptiske - hetlioz er indisert for behandling av ikke-24-timers sove-våkne lidelse (non-24) i helt blind voksne.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

allergan pharmaceuticals international ltd - bukspyttkjertelpulver - eksokrine bukspyttkjertelinsuffisiens - fordøyelsesmidler, inkl. enzymer - behandling av kreft i bukspyttkjertelen i eksokrin pankreatisk insuffisiens på grunn av cystisk fibrose eller andre forhold (e. kronisk pankreatitt, etter pankreatektomi eller kreft i bukspyttkjertelen). enzepi er angitt i spedbarn, barn, ungdom og voksne.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

merz pharmaceuticals gmbh - memantinhydroklorid - alzheimers sykdom - andre anti-demens medisiner - behandling av pasienter med moderat til alvorlig alzheimers sykdom.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

merz pharmaceuticals gmbh   - memantinhydroklorid - alzheimers sykdom - andre anti-demens medisiner - behandling av pasienter med moderat til alvorlig alzheimers sykdom.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/9/2021 (h3n2) - like strain (a/darwin/6/2021, ivr-227) / a/victoria/4897/2022 (h1n1) pdm09-like strain (a/victoria/4897/2022, ivr-238) / b/phuket/3073/2013-like strain (b/phuket/3073/2013, bvr-1b) / influenza virus b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - influensa, human - vaksiner - forebygging av influensa hos eldre (65 år og eldre). fluad tetra bør brukes i samsvar med offisielle anbefalinger.

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - zoledronsyre - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - legemidler til behandling av bein sykdommer - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture, including those with a recent low-trauma hip fracture. behandling av osteoporose forbundet med langvarig systemisk glukokortikoid terapi i innlegget postmenopausale kvinner og hos menn med økt risiko for brudd. behandling av pagets sykdom i beinet.